Literature DB >> 19272284

The role of nerve blocks and botulinum toxin injections in the management of cluster headaches.

Jessica Ailani1, William B Young.   

Abstract

Cluster headache (CH) is a primary headache syndrome that is classified with the trigeminal autonomic cephalalgias. CH treatment involves three steps: acute attack management, transitional therapy, and preventive therapy. Greater occipital nerve block has been shown to be an effective alternative bridge therapy to oral steroids in CH. Botulinum toxin type A has recently been studied as a new preventive treatment for patients with chronic CH, with limited success.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19272284     DOI: 10.1007/s11916-009-0028-7

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  21 in total

1.  Stimulation of the superior sagittal sinus increases metabolic activity and blood flow in certain regions of the brainstem and upper cervical spinal cord of the cat.

Authors:  P J Goadsby; A S Zagami
Journal:  Brain       Date:  1991-04       Impact factor: 13.501

2.  Functional connectivity between trigeminal and occipital nerves revealed by occipital nerve blockade and nociceptive blink reflexes.

Authors:  V Busch; W Jakob; T Juergens; W Schulte-Mattler; H Kaube; A May
Journal:  Cephalalgia       Date:  2006-01       Impact factor: 6.292

Review 3.  Cluster headache.

Authors:  D W Dodick; T D Rozen; P J Goadsby; S D Silberstein
Journal:  Cephalalgia       Date:  2000-11       Impact factor: 6.292

Review 4.  Cluster headache: pathogenesis, diagnosis, and management.

Authors:  Arne May
Journal:  Lancet       Date:  2005 Sep 3-9       Impact factor: 79.321

5.  Greater occipital nerve blockade for cluster headache.

Authors:  M F P Peres; M A Stiles; H C Siow; T D Rozen; W B Young; S D Silberstein
Journal:  Cephalalgia       Date:  2002-09       Impact factor: 6.292

6.  Melatonin versus placebo in the prophylaxis of cluster headache: a double-blind pilot study with parallel groups.

Authors:  M Leone; D D'Amico; F Moschiano; F Fraschini; G Bussone
Journal:  Cephalalgia       Date:  1996-11       Impact factor: 6.292

Review 7.  Evidence for antinociceptive activity of botulinum toxin type A in pain management.

Authors:  K Roger Aoki
Journal:  Headache       Date:  2003 Jul-Aug       Impact factor: 5.887

8.  Occipital nerve blockade in chronic cluster headache patients and functional connectivity between trigeminal and occipital nerves.

Authors:  V Busch; W Jakob; T Juergens; W Schulte-Mattler; H Kaube; A May
Journal:  Cephalalgia       Date:  2007-09-10       Impact factor: 6.292

9.  The first 5 minutes after greater occipital nerve block.

Authors:  William Young; Brianna Cook; Shahram Malik; James Shaw; Michael Oshinsky
Journal:  Headache       Date:  2008-06-28       Impact factor: 5.887

10.  Botulinum toxin type-A therapy in cluster headache: an open study.

Authors:  Petra Sostak; Phillip Krause; Stefanie Förderreuther; Veronika Reinisch; Andreas Straube
Journal:  J Headache Pain       Date:  2007-09-24       Impact factor: 7.277

View more
  2 in total

1.  Designing studies for cluster headache: lessons learned.

Authors:  Marcelo E Bigal
Journal:  Curr Pain Headache Rep       Date:  2011-08

2.  Ganglion impar block with botulinum toxin type a for chronic perineal pain -a case report-.

Authors:  Su Jin Lim; Hue Jung Park; Sang Hoon Lee; Dong Eon Moon
Journal:  Korean J Pain       Date:  2010-03-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.